Flexible Acetylcholine Neural Probe with a Hydrophobic Laser-Induced Graphene Electrode and a Fluorous-Phase Sensing Membrane.

ACS Mater Lett

Alfred E. Mann Department of Biomedical Engineering, Viterbi School of Engineering, University of Southern California, Los Angeles, California 90089, United States.

Published: September 2024

This work develops the first laser-induced graphene (LIG)-based electrochemical sensor with a superhydrophobic fluorous membrane for a flexible acetylcholine (ACh) sensor. ACh regulates several physiological functions, including synaptic transmission and glandular secretion. The ACh sensing membrane is doped with a fluorophilic cation-exchanger that can selectively measure ACh based on the inherent selectivity of the fluorous phase for hydrophobic ions, such as ACh. The fluorous-phase sensor improves the selectivity for ACh over Na and K by 2 orders of magnitude (compared to traditional lipophilic membranes), thus lowering the detection limit in artificial cerebrospinal fluid (aCSF) from 331 to 0.38 M, thereby allowing measurement in physiologically relevant ranges of ACh. Engraving LIG under argon creates a hydrophobic surface with a 133.7° contact angle, which minimizes the formation of a water layer. The flexible solid-contact LIG fluorous sensor exhibited a slope of 59.3 mV/decade in aCSF and retained function after 20 bending cycles, thereby paving the way for studying ACh's role in memory and neurodegenerative diseases.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11415234PMC
http://dx.doi.org/10.1021/acsmaterialslett.4c00825DOI Listing

Publication Analysis

Top Keywords

flexible acetylcholine
8
laser-induced graphene
8
sensing membrane
8
ach
7
acetylcholine neural
4
neural probe
4
probe hydrophobic
4
hydrophobic laser-induced
4
graphene electrode
4
electrode fluorous-phase
4

Similar Publications

Dynamic responses of striatal cholinergic interneurons control behavioral flexibility.

Sci Adv

December 2024

Department of Neuroscience and Experimental Therapeutics, College of Medicine, Texas A&M University Health Science Center, Bryan, TX, USA.

Striatal cholinergic interneurons (CINs) are key to regulating behavioral flexibility, involving both extinguishing learned actions and adopting new ones. However, the mechanisms driving these processes remain elusive. In this study, we initially demonstrate that chronic alcohol consumption disrupts the burst-pause dynamics of CINs and impairs behavioral flexibility.

View Article and Find Full Text PDF

Introduction: The pedunculopontine nucleus (PPN) plays a role in coordinating complex behaviors and adapting to changing environmental conditions. The specific role of cholinergic neurons in PPN function is not well understood, but their ascending connectivity with basal ganglia and thalamus suggests involvement in adaptive functions.

Methods: We used a chemogenetic approach in ChAT::Cre rats to explore the specific contribution of PPN cholinergic neurons to behavioral flexibility, focusing on the adaptation to shifting reward contingencies in a Reversal Learning Task.

View Article and Find Full Text PDF
Article Synopsis
  • Autism spectrum disorder (ASD) includes a range of neurodevelopmental conditions with core behavioral symptoms critical for diagnosis, linked to altered dopamine (DA) neurotransmission in the striatum.
  • Research in a mouse model with elevated eukaryotic initiation factor 4E (eIF4E) expression shows that this increase leads to behavioral inflexibility and impaired DA release in the striatum.
  • These impairments stem from defective nicotinic receptor signaling affecting calcium dynamics in dopaminergic axons, highlighting the complex interactions between eIF4E, DA neurotransmission, and ASD symptoms, which could guide future therapies.
View Article and Find Full Text PDF

Efgartigimod: A Review in Generalised Myasthenia Gravis.

Drugs

November 2024

Springer Nature, Private Bag 65901, Mairangi Bay, Auckland, 0754, New Zealand.

Efgartigimod (Vyvgart; Vyvgart Hytrulo) is a neonatal fragment crystallizable receptor (FcRn) antagonist indicated for the treatment of generalised myasthenia gravis (gMG) in adults who are acetylcholine receptor (AChR) antibody positive (Ab+). Efgartigimod is approved for both intravenous (IV) and subcutaneous (SC) use. In a pivotal phase III trial, IV efgartigimod was associated with significant and clinically meaningful improvements in myasthenia gravis symptoms and reductions in disease burden.

View Article and Find Full Text PDF

Community-based reconstruction and simulation of a full-scale model of the rat hippocampus CA1 region.

PLoS Biol

November 2024

Blue Brain Project, École polytechnique fédérale de Lausanne (EPFL), Campus Biotech, Geneva, Switzerland.

The CA1 region of the hippocampus is one of the most studied regions of the rodent brain, thought to play an important role in cognitive functions such as memory and spatial navigation. Despite a wealth of experimental data on its structure and function, it has been challenging to integrate information obtained from diverse experimental approaches. To address this challenge, we present a community-based, full-scale in silico model of the rat CA1 that integrates a broad range of experimental data, from synapse to network, including the reconstruction of its principal afferents, the Schaffer collaterals, and a model of the effects that acetylcholine has on the system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!